1. Home
  2. NVRI vs DCTH Comparison

NVRI vs DCTH Comparison

Compare NVRI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enviri Corporation

NVRI

Enviri Corporation

HOLD

Current Price

$22.35

Market Cap

582.1M

Sector

Miscellaneous

ML Signal

HOLD

DCTH

Delcath Systems Inc.

N/A

Current Price

$16.35

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NVRI
DCTH
Founded
1853
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
582.1M
578.4M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
NVRI
DCTH
Price
$22.35
$16.35
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
340.9K
702.7K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
0.04
Revenue
N/A
N/A
Revenue This Year
$3.87
$24.54
Revenue Next Year
$3.70
$33.15
P/E Ratio
N/A
$409.75
Revenue Growth
N/A
N/A
52 Week Low
$10.81
$8.12
52 Week High
$24.20
$17.42

Technical Indicators

Market Signals
Indicator
NVRI
DCTH
Relative Strength Index (RSI) 56.37 58.70
Support Level $17.79 $8.57
Resistance Level $23.77 $17.42
Average True Range (ATR) 1.18 0.54
MACD 0.24 -0.15
Stochastic Oscillator 74.65 14.96

Price Performance

Historical Comparison
NVRI
DCTH

About NVRI Enviri Corporation

Enviri Corp provides environmental and operational solutions to the metal and rail industries. It is based in Philadelphia, Pennsylvania, and operates in more than 30 countries. The company leverages industrial expertise to help customers improve operational performance, recover value from byproducts, enhance sustainability, and maintain critical infrastructure. Its divisions are Harsco Environmental and Harsco Rail, which combine deep operational capabilities with technologies and world-wide scale to deliver long-term value for customers, communities, and shareholders.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: